orforglipron vs oral semaglutide IGR: New weight-loss pill beats Ozempic in major trial A once-daily weight-loss pill, orforglipron, has outperformed the leading oral in a major Phase 3 clinical trial involving adults with Type Orforglipron, an Oral Small-Molecule GLP-1
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

00202-3/asset/7c9ee60c-81a4-493f-89fd-d6f37616dfa3/main.assets/gr3_lrg.jpg)























